1 in 3 Indians Has High Cholesterol. Most Are Managing It With Statins but You Have the Key to Reverse It.
Book Your Root Cause Analysis
High Cholesterol Isn't What You Think It Is
High Cholesterol Isn't What You Think It Is
Cholesterol is not the enemy. It is an essential molecule, the raw material for sex hormones, vitamin D, bile acids, and cell membrane integrity. Every cell in the body requires cholesterol to function. The problem is not cholesterol itself but the context in which it operates. Elevated LDL cholesterol in isolation is a poor predictor of cardiovascular risk. What matters is the pattern, the size and oxidation state of LDL particles, the ratio of triglycerides to HDL, the inflammatory burden that drives cholesterol into arterial walls, and the insulin resistance that underlies abnormal lipid metabolism in the vast majority of cases. A total cholesterol number tells almost none of this story.
The idea that dietary fat raises cholesterol and causes heart disease, the diet-heart hypothesis has been substantially revised by decades of subsequent research. Dietary cholesterol has minimal impact on blood cholesterol levels in most people. Saturated fat affects LDL particle size more than LDL quantity shifting toward larger, less atherogenic particles. The primary dietary driver of atherogenic dyslipidaemia such as high triglycerides, low HDL, and small dense LDL is refined carbohydrate and sugar consumption, not dietary fat. Yet the standard advice remains to reduce fat intake while the carbohydrate consumption driving the lipid pattern continues unaddressed.
A standard lipid panel measures total cholesterol, LDL, HDL, and triglycerides. It does not measure LDL particle size, small dense LDL particles are significantly more atherogenic than large buoyant ones and two people with identical LDL readings can have dramatically different cardiovascular risk based on particle size alone. It does not measure oxidised LDL, the form that actually deposits in arterial walls. It does not measure Lp(a), a genetically determined lipoprotein that is one of the strongest independent cardiovascular risk factors. And it does not assess the insulin resistance and inflammation that drive abnormal lipid metabolism in the first place.
Indians have a genetic predisposition toward atherogenic dyslipidaemia specifically elevated triglycerides, low HDL, and small dense LDL at lower total cholesterol levels than Western populations. This pattern is driven primarily by the high refined carbohydrate dietary transition of recent decades, high rates of insulin resistance, widespread physical inactivity, chronic stress, and sedentary urban lifestyles. Indians develop cardiovascular disease at younger ages and lower cholesterol levels than Western populations making the standard cholesterol thresholds used for treatment decisions systematically inappropriate for the Indian population.
Abnormal cholesterol is almost always a downstream consequence of insulin resistance and chronic inflammation not a primary condition requiring lifelong medication. Statins lower LDL effectively but do not address insulin resistance, do not reduce triglycerides meaningfully, do not raise HDL substantially, and do not address the oxidative and inflammatory environment that drives atherogenesis. Address the metabolic and inflammatory drivers and the lipid pattern very often normalises without medication or responds dramatically better to lower medication doses.
The Difference Between Lowering Cholesterol and Fixing the System
CONVENTIONAL MEDICINE
- Standard lipid panel measuring total cholesterol, LDL, HDL, and triglycerides
- Statins as primary treatment for elevated LDL
- Advice to reduce dietary fat and cholesterol intake
- No assessment of LDL particle size, oxidised LDL, or Lp(a)
- No investigation into insulin resistance, inflammation, or gut health
- No follow up on why lipid metabolism is dysregulated
FUNCTIONAL NUTRITION
- Root Cause Analysis with 60+ functional markers
- Advanced lipid panel including LDL particle size, oxidised LDL, and Lp(a)
- Fasting insulin, HOMA-IR, and full glucose metabolism panel
- Inflammatory markers including hsCRP and homocysteine
- Liver function, bile acid metabolism, and thyroid panel
- Gut health and microbiome markers
- A dedicated functional nutritionist guides every step
High Cholesterol Isn't One Problem. It's Multiple Root Causes Working Together.
Three steps to finally understanding your body
Book your Root Cause Analysis
Get your blood work done at Home
Sit down with your nutritionist
What Starts as High Cholesterol Doesn't End There
73% of clients with dyslipidaemia reported measurable improvement in triglycerides, HDL, and inflammatory markers within the first 60 days of their personalised protocol without increasing their medication.
They felt the same way you do right now.
.png)
Before
After
Before
After
Before
After
Before
After
Before
After
Before
After
Before
After
Before
After
Before
After
Before
After
Before
After
Before
After
Before
After
Before
After
How We Find and Fix the Root Cause of High Cholesterol
Personalised Diet Protocol
Smart Supplementation
Lifestyle Interventions
FAQs
That is a decision to make with your doctor based on your overall cardiovascular risk profile, and not LDL alone. What is important to know is that statins lower LDL but do not address the insulin resistance, inflammation, and metabolic dysfunction driving abnormal lipid metabolism. Many people who address those drivers see dramatic improvements in their full lipid pattern without medication or at significantly lower doses. The root cause investigation should happen regardless of the medication decision.
For the majority of people whose dyslipidaemia is driven by insulin resistance and chronic inflammation rather than genetic factors, meaningful and sustained normalisation of the lipid pattern is achievable through targeted nutritional and metabolic intervention. Statins become unnecessary rather than mandatory when the metabolic terrain generating the abnormal lipid pattern is corrected.
Because dietary fat is not the primary driver of atherogenic dyslipidaemia in most people. Refined carbohydrates drive triglyceride elevation, HDL suppression, and small dense LDL production, the lipid pattern most strongly associated with cardiovascular risk. Reducing fat while maintaining high carbohydrate intake addresses the wrong variable and frequently worsens the triglyceride to HDL ratio that matters most.
No. Total cholesterol and LDL in isolation are poor predictors of cardiovascular risk. LDL particle size, oxidised LDL, Lp(a), triglyceride to HDL ratio, and inflammatory markers including hsCRP and homocysteine tell a substantially more complete and accurate cardiovascular risk story. Many people with normal LDL have high cardiovascular risk and many with elevated LDL have low risk, the standard panel cannot distinguish between them.
Statins are generally well tolerated but long term use is associated with depletion of CoQ10, an essential mitochondrial cofactor which is the primary mechanism behind the muscle pain and fatigue that many people experience on statins. They also modestly elevate diabetes risk particularly in people with underlying insulin resistance. These are not reasons to avoid statins when they are genuinely indicated but they are reasons to address the root causes that make statins necessary in the first place.
Star Your Root Cause Analysis
.svg){kind=logo}
Banking
What’s Included in Your Blood Analysis?
We’re Not In Your City Yet But We’re Not Letting You Go.
You Still Get:
- Free 1:1 consultation with our clinical team
- Symptom + history deep dive
- Direction on what’s actually driving your condition
- Guidance on next best steps (tests, diet, and protocol)
Talk to our team
Talk to our team
Download Now
